Cytoreductive surgery for peritoneal metastases in GIST
When to operate, how to select patients and what to expect after tyrosine kinase inhibitor therapy: commentary on the review article published in Clinical and Translational Oncology (2026)
Review published in Clinical and Translational Oncology with the participation of Prof. Luis González Bayón. Cytoreductive surgery in GIST with peritoneal metastases, after 6-12 months of TKI and with a multidisciplinary decision, reaches 5-year survival of up to 80% in selected patients.
References
Published in: Clinical and Translational Oncology · Springer (2026)
DOI: 10.1007/s12094-025-04172-w
View original article